Cranial hypertrophic pachymeningitis with myelodysplastic syndrome.
Hypertrophic pachymeningitis
Myelodysplastic syndrome
Steroids therapy
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
30 Jun 2024
30 Jun 2024
Historique:
received:
21
09
2023
revised:
12
06
2024
accepted:
12
06
2024
medline:
11
7
2024
pubmed:
11
7
2024
entrez:
11
7
2024
Statut:
epublish
Résumé
Hypertrophic pachymeningitis (HP) is a rare inflammatory disease characterized by thickening of the dura mater. HP develops with several inflammatory diseases. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and IgG4 related disease are reported as 2 major causes. With hematologic diseases, only 3 cases have been reported. We report the case of myelodysplastic syndrome (MDS) developing HP. Our case provides a thought-provoking hypothesis regarding the potential relationship between MDS and HP.
Identifiants
pubmed: 38988571
doi: 10.1016/j.heliyon.2024.e32973
pii: S2405-8440(24)09004-2
pmc: PMC11233996
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
e32973Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Tsutomu Sato reports financial support, article publishing charges, and writing assistance were provided by 10.13039/501100001691Japan Society for the Promotion of Science.